These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside. Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638 [TBL] [Abstract][Full Text] [Related]
24. Nicotinamide mononucleotide reduces melanin production in aged melanocytes by inhibiting cAMP/Wnt signaling. Brito S; Baek JM; Cha B; Heo H; Lee SH; Lei L; Jung SY; Lee SM; Lee SH; Kwak BM; Chae S; Lee MG; Bin BH J Dermatol Sci; 2022 Jun; 106(3):159-169. PubMed ID: 35610161 [TBL] [Abstract][Full Text] [Related]
25. Enhancing the biosynthesis of nicotinamide mononucleotide in Lactococcus lactis by heterologous expression of FtnadE. Kong LH; Liu TY; Yao QS; Zhang XH; Xu WN; Qin JY J Sci Food Agric; 2023 Jan; 103(1):450-456. PubMed ID: 36205212 [TBL] [Abstract][Full Text] [Related]
26. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death. Wang X; Hu X; Yang Y; Takata T; Sakurai T Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898 [TBL] [Abstract][Full Text] [Related]
27. Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD Liu Y; Luo C; Li T; Zhang W; Zong Z; Liu X; Deng H J Proteome Res; 2021 May; 20(5):2596-2606. PubMed ID: 33793246 [TBL] [Abstract][Full Text] [Related]
28. β-Nicotinamide Mononucleotide, an Anti-Aging Candidate Compound, Is Retained in the Body for Longer than Nicotinamide in Rats. Kawamura T; Mori N; Shibata K J Nutr Sci Vitaminol (Tokyo); 2016; 62(4):272-276. PubMed ID: 27725413 [TBL] [Abstract][Full Text] [Related]
29. β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice. Li HR; Liu Q; Zhu CL; Sun XY; Sun CY; Yu CM; Li P; Deng XM; Wang JF Redox Biol; 2023 Jul; 63():102745. PubMed ID: 37201414 [TBL] [Abstract][Full Text] [Related]
30. Effect of Exercise and Oral Niacinamide Mononucleotide on Improving Mitochondrial Autophagy in Alzheimer's Disease. Wu W; Yuan S; Tang Y; Meng X; Peng M; Hu Z; Liu W Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447179 [TBL] [Abstract][Full Text] [Related]
31. [Advances in physiological activities and synthesis of β-nicotinamide mononucleotide]. Chen Y; Zhou C; Huang J; Tao Y; Ke C; Yang X Sheng Wu Gong Cheng Xue Bao; 2023 Feb; 39(2):516-536. PubMed ID: 36847087 [TBL] [Abstract][Full Text] [Related]
32. Host-microbiome interactions in nicotinamide mononucleotide (NMN) deamidation. Kim LJ; Chalmers TJ; Madawala R; Smith GC; Li C; Das A; Poon EWK; Wang J; Tucker SP; Sinclair DA; Quek LE; Wu LE FEBS Lett; 2023 Sep; 597(17):2196-2220. PubMed ID: 37463842 [TBL] [Abstract][Full Text] [Related]
33. Research advances in the function and anti-aging effects of nicotinamide mononucleotide. Wang M; Cao Y; Li Y; Wang L; Liu Y; Deng Z; Zhu L; Kang H J Zhejiang Univ Sci B; 2024 Sep; 25(9):723-735. PubMed ID: 39308064 [TBL] [Abstract][Full Text] [Related]
34. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction. Kahn B; Borrelli M; Libby T J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044 [TBL] [Abstract][Full Text] [Related]
35. Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons. Chandrasekaran K; Choi J; Arvas MI; Salimian M; Singh S; Xu S; Gullapalli RP; Kristian T; Russell JW Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466541 [TBL] [Abstract][Full Text] [Related]
36. Nicotinamide mononucleotide alters body composition and ameliorates metabolic disorders induced by a high-fat diet. Zhang Y; Zhu W; Wang M; Xi P; Wang H; Tian D IUBMB Life; 2023 Jun; 75(6):548-562. PubMed ID: 36785893 [TBL] [Abstract][Full Text] [Related]
37. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Irie J; Inagaki E; Fujita M; Nakaya H; Mitsuishi M; Yamaguchi S; Yamashita K; Shigaki S; Ono T; Yukioka H; Okano H; Nabeshima YI; Imai SI; Yasui M; Tsubota K; Itoh H Endocr J; 2020 Feb; 67(2):153-160. PubMed ID: 31685720 [TBL] [Abstract][Full Text] [Related]
38. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Braidy N; Liu Y Exp Gerontol; 2020 Apr; 132():110831. PubMed ID: 31917996 [TBL] [Abstract][Full Text] [Related]
39. Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging? Wei Z; Chai H; Chen Y; Cheng Y; Liu X Curr Opin Pharmacol; 2021 Oct; 60():291-297. PubMed ID: 34507029 [TBL] [Abstract][Full Text] [Related]
40. Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN/NAD consumers mediated by Twist2. Hasegawa K; Sakamaki Y; Tamaki M; Wakino S Sci Rep; 2022 Aug; 12(1):13712. PubMed ID: 35962139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]